11/14/2024 2:24 PM | ARMISTICE CAPITAL, LLC (Filed by) Brainstorm Cell Therapeutics (Subject)
| Form SC 13G | |
11/13/2024 6:55 AM | Brainstorm Cell Therapeutics (Subject) Ruck Matthew J (Filed by)
| Form SC 13G | |
10/30/2024 7:41 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2024 7:00 AM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 7:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/29/2024 11:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form EFFECT | |
09/26/2024 3:30 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
09/24/2024 3:30 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3/A | |
09/17/2024 2:32 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
09/16/2024 3:36 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/08/2024 11:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form EFFECT | |
08/28/2024 4:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/16/2024 6:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form DEF 14A | |
08/16/2024 6:03 AM | Brainstorm Cell Therapeutics (Filer)
| Form ARS | |
08/14/2024 7:01 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024 6:15 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/31/2024 3:08 PM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024 3:09 PM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024 3:05 PM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024 3:06 PM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024 3:06 PM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024 3:07 PM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024 3:07 PM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4/A | |
07/24/2024 3:05 PM | Brainstorm Cell Therapeutics (Issuer) Dagher Ibrahim B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 3:05 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2024 9:49 AM | Brainstorm Cell Therapeutics (Filer)
| Form 424B5 | |
06/28/2024 6:30 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/27/2024 8:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form 424B5 | |
06/26/2024 3:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 8:03 PM | Brainstorm Cell Therapeutics (Issuer) HARTOUNIAN HARTOUN (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/25/2024 8:04 PM | Brainstorm Cell Therapeutics (Issuer) HARTOUNIAN HARTOUN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 4:24 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2024 5:05 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/03/2024 8:00 AM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 5:00 AM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2024 6:53 AM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 6:41 PM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 8:14 AM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2024 3:06 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/25/2024 3:01 PM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 7:06 PM | Brainstorm Cell Therapeutics (Issuer) Dagher Ibrahim B. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad) The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you.
A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide |
04/19/2024 5:05 AM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 8:31 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 5:10 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/09/2024 5:05 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 3:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2024 8:16 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
04/01/2024 7:15 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 7:54 PM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 7:55 PM | Brainstorm Cell Therapeutics (Issuer) Patlis Alla (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 7:56 PM | Brainstorm Cell Therapeutics (Issuer) Yablonka Uri (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 7:57 PM | Brainstorm Cell Therapeutics (Issuer) Lindborg Stacy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 9:06 AM | Brainstorm Cell Therapeutics (Subject) Ness Kevin Dean (Filed by)
| Form SC 13G/A | |
12/20/2023 4:04 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 5:03 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |